StreetAlpha.app
Home › Stocks › SOPH

SOPHiA GENETICS SA (SOPH)

Healthcare
$7.45
▲ +0.13%
LAST CLOSE · NOV 17

SOPHiA GENETICS sells a cloud based software platform that analyzes medical data for hospitals, labs and drug companies. It last closed at $7.45 on Nov 17, up 0.13% on the day.

AI Auto Pilots
Is SOPH in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$77.3M
+18.6% vs a year ago
Net income
−$79.0M
−102.2% margin
Free cash flow
−$36.5M
−47.2% margin
Gross margin
67.4%
$52.1M gross profit
Balance sheet
Cash & equivalents
$70.3M
At Dec 31
Shareholder equity
$47.1M
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $40.5M$40.5MFY2021FY2022: $47.6M$47.6MFY2022FY2023: $62.4M$62.4MFY2023FY2024: $65.2M$65.2MFY2024FY2025: $77.3M$77.3MFY2025

From SOPH's SEC filings, latest 20-F for the period ending Dec 31, 2025 (filed Mar 3). Last 12 months adds up the four latest quarters. Per share figures are left out because the US listing can represent a different number of shares.

Next report
—
No date on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
—
No ratings in 90 days
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
No firm has rated SOPH in the past 90 days.
Average 12-month target
No price targets on SOPH in the past 90 days.
Latest rating changes
HC Wainwright & Co.Target raised
Aug 5Buy$12 → $14
BTIGTarget raised
Aug 5Buy$8 → $9
HC Wainwright & Co.Initiated
Jul 20Buy$12
BTIGReiterated
Jun 15Buy$8
DateFirmActionRatingPrice target
Aug 5HC Wainwright & Co.Target raisedBuy$12 → $14
Aug 5BTIGTarget raisedBuy$8 → $9
Jul 20HC Wainwright & Co.InitiatedBuy$12
Jun 15BTIGReiteratedBuy$8
Loading…

Technical Analysis

SOPH · as of the Nov 17 close · updated after every close
Moving sideways

The stock sits between its 20 and 50 day averages. It is 18% above its 200 day average, so the longer trend is still up. Momentum is improving (RSI 50). The nearest support is the 20 day average at $7.44, and the nearest resistance the swing high (Oct 16) at $7.48.

Short trendNeutral
Long trendBullish
MomentumImproving
StretchNormal
VolatilityHigh, 7.4%/day
Key levels
$8.9852 week high+20.5%
$7.6250 day average+2.3%
$7.58Pivot R1+1.7%
$7.48Swing high (Oct 16)+0.4%
$7.45Last close
$7.4420 day average−0.1%
$7.37Swing low (Aug 13)−1.1%
$7.35Pivot−1.3%
$7.24100 day average−2.8%
$7.22Pivot S1−3.1%
$6.07200 day average−18.5%
$3.8352 week low−48.6%
Indicators
RSI (14)49.59Middle of its rangeNeutral
MACD0.04Above its signal lineBullish
Stochastic74.2Middle of its rangeNeutral
ADX (14)15.2No clear trend
Williams %R-36.3Oversold below −80, overbought above −20Neutral
CCI (20)-10.3Oversold below −100, overbought above 100Neutral
Rate of change+7.8%Change over 10 sessionsBullish
ATR (14)$0.55Typical daily range, 7.4% of price
MA 10Above
MA 20Above
MA 50Below
MA 100Above
MA 200Above
What happened before, for SOPH

What happened before

See how SOPH did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow SOPH usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How SOPH has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in SOPH in the last 90 days.

Loading…

See today’s whale options flow across the market →

SOPH Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲57 buying vs 36 selling
  • ▲Shares held by funds +11.2%
  • ▲Funds holding +20
  • ▲Superinvestors: 4 added, 0 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding9373+27.4%
In funds' top 10110.0%
Held by funds–––
New / increased31 / 2628 / 16+29.5%
Reduced / sold out25 / 1115 / 4+89.5%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See SOPH institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SOPH is in one of them and how their past SOPH trades turned out.

SOPH in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered SOPH in an article yet. Here's the latest on the wider market.

About SOPHiA GENETICS SA

SOPHiA GENETICS is a software company based in Rolle, Switzerland. Its cloud based platform, SOPHiA DDM, standardizes and analyzes health data such as genomic, radiomic and clinical information, so institutions can share insights without moving their samples or data. The company sells mainly to hospitals, clinical and research laboratories, and biopharmaceutical companies.

Headquarters
Rolle, Switzerland